Cetrolix Protocol versus Conventional Clomiphene Citrate Protocol in Women with Unexplained Infertility Undergoing Intrauterine Insemination: A Randomised Prospective Study
Journal: Journal of Gynecological Research and Obstetrics (Vol.2, No. 1)Publication Date: 2016-12-21
Authors : Mostafa F; Farid L;
Page : 068-071
Keywords : Cetrolix; Clomiphene citrate; Unexplained infertility; Intruterine insemination;
Abstract
Objective: The primary goal of this study was to compare the ovulation and pregnancy rates in women with unexplained infertility undergoing intrauterine insemination utilizing an antagonist (cetrolix) protocol versus the commonly used clomiphene citrate regimen.
Patients and Methods: This was a randomized controlled study performed at Assisted Reproductive Techniques Center of Ain Shams University Maternity Hospital, over a 2-year period, between Jan 2014 and Jan 2016, and included 80 women,with unexplained infertility undergoing intrauterine insemination (IUI), were randomised into two groups. Group I (n=40) received the antagonist protocol: human menopausal gonadotropins were given from Day 2 to reach a dominant follicle of 18-22 mm, intramuscularly. Then, cetrolix (0.25 mg) was subcutaneously started from Day 6 or Day 7 until the day of human chorionic gonadotropins (hCG; that was given in the dose of 10,000 IU, intramuscularly) when follicles reached 18-22 mm. Group II (n=40) receivd the clomiphene citrate protocol: clomiphene citrate given 100 mg/d from Day 2 to Day 6 and then human menopausal gonadotropin (hMG) to reach a dominant follicle of 18-22 mm, intramuscularly. Follow up until day of hCG, afterward, the IUI of 0.5mL was done from 34 hours to 36 hours using IUI catheter without guidance of ultrasonography and with an empty urinary bladder. The primary outcome was clinical pregnancy rate defined as the presence of intrauterine gestational sac detected by ultrasound at 5-weeks' gestation . The number of dominant follicles, level of serum estradiol, and luteinizing hormone at the day of hCG injection and the incidence of twin or triplet pregnancies in both groups were secondary outcome measures.
Other Latest Articles
- Prediction of Ovarian Response in Women with Premature Ovarian Insufficiency Stimulated By Gonadotrophins Using Day-3 Serum Estradiol: A Retrospective Study
- A Case of Severe, Silent Fetomaternal Haemorrhage (FMH) Detected by Mixed-Field in the Mother’s ABO Typing
- Pseudomemberanous Colitis following Cesarean Delivery with Adjunctive Intracolonic Vancomycin
- Ovarian Ectopic Pregnancy after Endometriomal Cyst Resection, Following In vitro Fertilization (IVF): A Rare Case Report
- Lack of Association between the 4234G/C X-Ray Repair Cross- Complementing 2 (XRCC2) Gene Polymorphism and the Risk of Endometrial Cancer among Polish Population
Last modified: 2018-09-26 16:25:07